RNA biotech Arc­turus boots CEO Joseph Payne

Just a few months af­ter do­ing a string of RNA deals with J&J, Cure­Vac and oth­ers in the wake of a re­verse merg­er on­to Nas­daq, Arc­turus $ARCT CEO Joseph Payne is out.

In a state­ment out this morn­ing the com­pa­ny said that the board had de­cid­ed to ter­mi­nate Payne, go­ing on­ly so far as to rule out op­er­a­tional per­for­mance, on­go­ing pro­grams, fi­nan­cial con­di­tion or fi­nan­cial re­port­ing as caus­es.

BD chief Mark Her­bert has been named in­ter­im pres­i­dent un­til a per­ma­nent re­place­ment is found.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER